Methods of using (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4- (methylamino) - 1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8naphthyridine-3carboxylic acid in combination therapy

Details for Australian Patent Application No. 2008317400 (hide)

Owner Sunesis Pharmaceuticals, Inc.

Inventors Silverman, Jeffrey A.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2008317400

PCT Pub. Number WO2009/054935

Priority 60/981,766 22.10.07 US

Filing date 21 October 2008

Wipo publication date 30 April 2009

International Classifications

A61K 31/282 (2006.01)

A61K 31/4178 (2006.01)

A61K 31/4375 (2006.01)

A61K 31/555 (2006.01) - containing heavy metals, e.g. hemin, hematin, melarsoprol

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

20 May 2010 PCT application entered the National Phase

  PCT publication WO2009/054935 Priority application(s): WO2009/054935

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008317402

2008317392-Method and system of generating audit procedures and forms